Sarcoma antigen 1 (715-723)

Sarcoma antigen 1 (715-723) is a synthetic peptide fragment derived from the C-terminal region of the sarcoma antigen 1 protein, a tumor-associated antigen recognized in various cancer immunology studies. As a defined peptide epitope, it is frequently utilized in the context of T cell recognition, immune monitoring, and the characterization of antigen-specific responses. Its precise sequence and immunogenic properties make it a valuable reagent for dissecting cellular immune mechanisms, particularly in the field of tumor immunology and antigen presentation research. The use of this peptide supports detailed investigations into the molecular interactions between tumor-associated antigens and the adaptive immune system, thereby contributing to a deeper understanding of immune surveillance and tumor escape.

Epitope mapping: Sarcoma antigen 1 (715-723) serves as a critical tool for mapping T cell epitopes within the sarcoma antigen 1 protein, allowing researchers to define the minimal amino acid sequence required for major histocompatibility complex (MHC) binding and T cell receptor recognition. By employing this peptide in in vitro assays, such as ELISPOT or intracellular cytokine staining, scientists can identify and characterize the specific cellular immune responses elicited by sarcoma antigens, thereby refining our understanding of antigenic determinants relevant to tumor immunity.

Antigen presentation studies: The peptide is widely used in studies investigating the presentation of tumor-associated antigens by antigen-presenting cells (APCs). By loading dendritic cells or other APCs with the sarcoma antigen 1 (715-723) epitope, researchers can assess the efficiency and specificity of antigen processing and presentation pathways. These experiments provide valuable insights into the mechanisms by which tumor-derived peptides are displayed on MHC molecules and recognized by cytotoxic T lymphocytes, advancing knowledge in cellular immunology and cancer biology.

Immunogenicity assessment: In preclinical research, the sarcoma antigen 1 (715-723) peptide is employed to evaluate the immunogenic potential of tumor antigens in various model systems. By stimulating peripheral blood mononuclear cells or splenocytes with the peptide, investigators can quantify antigen-specific T cell activation, cytokine secretion, and cytolytic activity. Such studies are essential for dissecting the immune landscape of sarcoma and related malignancies, informing the rational design of immunotherapeutic strategies and vaccine candidates.

Peptide-based assay development: This defined peptide fragment is instrumental in the development and optimization of peptide-based immunoassays that detect antigen-specific T cell responses. Its use enables the establishment of standardized protocols for monitoring immune responses in experimental settings, facilitating reproducibility and comparability across studies. By serving as a positive control or reference standard, the peptide supports the validation of assay sensitivity and specificity in immunological research.

Peptide synthesis and modification studies: The unique sequence of sarcoma antigen 1 (715-723) makes it an attractive model for exploring peptide synthesis techniques and post-synthetic modifications. Researchers can utilize the peptide to optimize solid-phase synthesis protocols, investigate structure-activity relationships, or introduce chemical modifications to enhance stability, binding affinity, or immunogenicity. These investigations contribute to the broader field of peptide chemistry and support the development of improved research reagents for immunological applications.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

3. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle